Bioline Rx reported $21.58M in Current Assets for its fiscal quarter ending in March of 2026.





Current Assets Change Date
Arca Biopharma USD 395.25M 51.39M Mar/2026
Bio Path USD 677K 14K Mar/2026
Bioline Rx USD 21.58M 2.1M Mar/2026
Capricor Therapeutics USD 283.09M 39.85M Mar/2026